Literature DB >> 32299756

Diagnosis and management of heparin-induced thrombocytopenia.

Yves Gruel1, Emmanuel De Maistre2, Claire Pouplard3, François Mullier4, Sophie Susen5, Stéphanie Roullet6, Normand Blais7, Grégoire Le Gal8, André Vincentelli9, Dominique Lasne10, Thomas Lecompte11, Pierre Albaladejo12, Anne Godier13.   

Abstract

Entities:  

Year:  2020        PMID: 32299756     DOI: 10.1016/j.accpm.2020.03.012

Source DB:  PubMed          Journal:  Anaesth Crit Care Pain Med        ISSN: 2352-5568            Impact factor:   4.132


× No keyword cloud information.
  14 in total

Review 1.  Heparin versus 0.9% sodium chloride locking for prevention of occlusion in central venous catheters in adults.

Authors:  Eduardo López-Briz; Vicente Ruiz Garcia; Juan B Cabello; Sylvia Bort-Martí; Rafael Carbonell Sanchis
Journal:  Cochrane Database Syst Rev       Date:  2022-07-18

Review 2.  Prevention of thrombotic risk in hospitalized patients with COVID-19 and hemostasis monitoring.

Authors:  Sophie Susen; Charles Ambroise Tacquard; Alexandre Godon; Alexandre Mansour; Delphine Garrigue; Philippe Nguyen; Anne Godier; Sophie Testa; Jerrold H Levy; Pierre Albaladejo; Yves Gruel
Journal:  Crit Care       Date:  2020-06-19       Impact factor: 9.097

Review 3.  Detection of Platelet-Activating Antibodies Associated with Heparin-Induced Thrombocytopenia.

Authors:  Brigitte Tardy; Thomas Lecompte; François Mullier; Caroline Vayne; Claire Pouplard
Journal:  J Clin Med       Date:  2020-04-24       Impact factor: 4.241

Review 4.  Heparin-Induced Thrombocytopenia: A Review of New Concepts in Pathogenesis, Diagnosis, and Management.

Authors:  Matteo Marchetti; Maxime G Zermatten; Debora Bertaggia Calderara; Alessandro Aliotta; Lorenzo Alberio
Journal:  J Clin Med       Date:  2021-02-10       Impact factor: 4.241

Review 5.  Recent Advances in Anticoagulant Treatment of Immune Thrombosis: A Focus on Direct Oral Anticoagulants in Heparin-Induced Thrombocytopenia and Anti-Phospholipid Syndrome.

Authors:  Julie Carré; Georges Jourdi; Nicolas Gendron; Dominique Helley; Pascale Gaussem; Luc Darnige
Journal:  Int J Mol Sci       Date:  2021-12-22       Impact factor: 5.923

6.  Caution in Using the Activated Partial Thromboplastin Time to Monitor Argatroban in COVID-19 and Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT).

Authors:  Susan Guy; Steve Kitchen; Michael Makris; Rhona M Maclean; Giorgia Saccullo; Joost J Vanveen
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

Review 7.  Platelet factor 4 polyanion immune complexes: heparin induced thrombocytopenia and vaccine-induced immune thrombotic thrombocytopenia.

Authors:  Payel Datta; Fuming Zhang; Jonathan S Dordick; Robert J Linhardt
Journal:  Thromb J       Date:  2021-09-15

8.  Vaccine-induced thrombotic thrombocytopenia (VITT): first report from India.

Authors:  Christy V John; Rajesh Kumar; Anil Kumar Sivan; Sangeetha Jithin; Rojin Abraham; Chepsy C Philip
Journal:  Thromb J       Date:  2022-03-04

Review 9.  Superior outcomes with Argatroban for heparin-induced thrombocytopenia: a Bayesian network meta-analysis.

Authors:  Giorgia Colarossi; Nicola Maffulli; Andromahi Trivellas; Heike Schnöring; Nima Hatam; Markus Tingart; Filippo Migliorini
Journal:  Int J Clin Pharm       Date:  2021-03-28

10.  An Optimized and Standardized Rapid Flow Cytometry Functional Method for Heparin-Induced Thrombocytopenia.

Authors:  Anne Runser; Caroline Schaning; Frédéric Allemand; Jean Amiral
Journal:  Biomedicines       Date:  2021-03-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.